메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 27, Issue 24, 2009, Pages
Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanoma
Author keywords

[No Author keywords available]
Indexed keywords

ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT;
EID: 69849092153     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.23.3874     Document Type: Letter
Times cited : (9)
References (5)
  • 1
    • 60849108348 scopus 로고    scopus 로고
    • Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patients with resected high-risk melanoma
    • Pectasides D, Dafni U, Bafaloukos D, et al: Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patients with resected high-risk melanoma. J Clin Oncol 27:939-944, 2009
    • (2009) J Clin Oncol , vol.27 , pp. 939-944
    • Pectasides, D.1    Dafni, U.2    Bafaloukos, D.3
  • 2
    • 0035883485 scopus 로고    scopus 로고
    • Interferon-mediated fatigue
    • suppl 6
    • Malik UR, Makower DF, Wadler S: Interferon-mediated fatigue. Cancer 92:1664-1668, 2001 (suppl 6)
    • (2001) Cancer , vol.92 , pp. 1664-1668
    • Malik, U.R.1    Makower, D.F.2    Wadler, S.3
  • 3
    • 0036727090 scopus 로고    scopus 로고
    • Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy
    • Kirkwood JM, Bender C, Agarwala S, et al: Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy. J Clin Oncol 20:3703-3718, 2002
    • (2002) J Clin Oncol , vol.20 , pp. 3703-3718
    • Kirkwood, J.M.1    Bender, C.2    Agarwala, S.3
  • 4
    • 76549111044 scopus 로고    scopus 로고
    • Health-related quality of life measures in melanoma patients receiving pulsed high-dose intravenous interferon alpha 2b (IFNα2b)
    • suppl; abstr 8536, 481s
    • Mohr P, Hauschild A, Trefzer U, et al: Health-related quality of life measures in melanoma patients receiving pulsed high-dose intravenous interferon alpha 2b (IFNα2b). J Clin Oncol 25:481s, 2007 (suppl; abstr 8536)
    • (2007) J Clin Oncol , vol.25
    • Mohr, P.1    Hauschild, A.2    Trefzer, U.3
  • 5
    • 37549034255 scopus 로고    scopus 로고
    • Interferon-alpha in oncology patients: Fewer psychiatric side effects than anticipated
    • Bannink M, Kruit WH, Van Gool AR, et al: Interferon-alpha in oncology patients: Fewer psychiatric side effects than anticipated. Psychosomatics 49:56-63, 2008
    • (2008) Psychosomatics , vol.49 , pp. 56-63
    • Bannink, M.1    Kruit, W.H.2    Van Gool, A.R.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.